Figure 2
From: Parenteral oestrogen in the treatment of prostate cancer: a systematic review

Overall mortality. Trials included in the figure are those where the parenteral oestrogen was PEP alone and for which data were fully reported. It should be noted that the follow-up times reported were not entirely uniform; where data for multiple time points were available those closest to 2 years are presented. Trials with zero events in any arm are not included in the figure.